During the treatment of heart failure with β-blockers (e.g., metoprolol), the inhibition of the β1-AR signaling pathway exerts a protective effect on the heart, alleviating cardiac hypertrophy and reducing the occurrence of arrhythmias. Here, ADRB1 is linked to Arrhythmia.